VRCA Verrica Pharmaceuticals reports narrower than expected Q4 2025 loss with shares slipping 157 in regular trading TELA Bio TELA posts narrower than expected Q4 2025 loss sending shares up 459 percent in todays trading Bleichroeder BBCQ strategic review ongoing as acquisition timeline remains uncertain amid market volatility How Certara CERT is reshaping its industry Smart Money Flows 20260506 BLFY Blue Foundry posts a slight Q3 2025 EPS miss as its share price holds steady today Why SuRo Capital SSSS might be early to something big Recovers 20260505 What Alta Equip ALTG subscription metrics reveal about retention Q1 2026 Profit Disappoints NXTT Next CEO expresses strong optimism for AI and cloud segments to drive sustained longterm growth MAPS WM Technology reports wide Q4 2025 EPS miss shares hold steady as investors await clearer guidance What implementation shortfall Capricor CAPR Dips 20260429 SEVN Seven reports narrow Q1 2026 EPS beat shares rise nearly 2 percent on upbeat investor reaction Heard on the Street Launches Eighth Annual StockPicking Contest CFR Frost Bank posts 62 percent first quarter 2026 EPS beat shares edge higher on upbeat investor reception How Morningstar MORN maintains its asset base Morningstar EPS beats by 17 What Coterra CTRA has done differently this quarter Coterra Misses EPS Estimates by 206 on Headwinds INNE Summit leadership reaffirms preferred dividend commitments as it refines its premium hotel portfolio strategy Regeneron Pharmaceuticals REGN Unveils C5 Complement Pipeline Strategy But Execution Risks Cap NearTerm Upside Moderna Inc MRNA PreEarnings Analysis Ahead of Q1 2026 Results Release Planet 13 Reports Weaker Q1 2026 Results Revenue Declines Net Loss Widens Bora Pharmaceuticals Acquires MacroGenics Facility for 1225M to Expand US Footprint ReMax Acquired in Latest Franchise Sector MA Wave